Cutler Group’s Lifestance Health LFST Stock Holding History

Cutler Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,100	Closed	-$1K	–	5767
2021 Q3	$1K	Buy	+1,100	New	+$21.2K	﹤0.01%	5348

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's LFST Position: Q1 2022 in Review

Cutler Group sold out of Lifestance Health (LFST) in Q1 2022, closing a stake of 122 shares — an estimated $1K sold.

Cutler Group first reported a position in LFST in Q3 2021 and held it in 2 quarters. The position peaked at $9K in Q3 2021. 73 funds tracked by Wall St. Rank hold LFST as of Q1 2022.

Cutler Group reported no remaining Lifestance Health position as of Q1 2022 after selling out during the quarter.
Cutler Group sold 122 Lifestance Health shares in Q1 2022, an estimated $1K.
Cutler Group first reported a position in Lifestance Health in Q3 2021 and held it in 2 quarters.
Cutler Group's Lifestance Health position peaked at $9K in Q3 2021.
73 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.